Sanara Medtech develops, markets and distributes biotechnology products to physicians, hospitals, nursing homes and clinics. Through its wholly-owned subsidiary, Wound Care Innovations, LLC, Co. provides CellerateRX®/CRXa® Activated Collagen® Adjuvant (CellerateRX) in the general wound care and surgical markets. CellerateRX is a medical device for use on all acute and chronic wounds, except third degree burns, and is sold in both powder and gel form. Through its 100% ownership of Cellerate, LLC, Co. is focused on delivering the CellerateRX product lines to hospitals and surgery centers as well as the diabetic care and long-term care markets. The SMTI stock yearly return is shown above.
The yearly return on the SMTI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SMTI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|